Cargando…

PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa

Detalles Bibliográficos
Autores principales:	Davey, Dvora L Joseph, Bekker, Linda-Gail, Mashele, Nyiko, Gorbach, Pamina, Coates, Thomas J, Myer, Landon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398649/ https://www.ncbi.nlm.nih.gov/pubmed/32758479 http://dx.doi.org/10.1016/S2352-3018(20)30226-5

Ejemplares similares

Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence
por: Moran, Alexander, et al.
Publicado: (2021)

Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa
por: Beesham, Ivana, et al.
Publicado: (2022)

Correction to: Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa
por: Beesham, Ivana, et al.
Publicado: (2022)

Early pre‐exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa
por: Joseph Davey, Dvora Leah, et al.
Publicado: (2022)

“I had Made the Decision, and No One was Going to Stop Me” —Facilitators of PrEP Adherence During Pregnancy and Postpartum in Cape Town, South Africa
por: Joseph Davey, Dvora L., et al.
Publicado: (2021)

Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: Programmatic implications for PrEP delivery
por: Joseph Davey, Dvora, et al.
Publicado: (2018)

Preferences and acceptability for long‐acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya
por: Wara, Nafisa J., et al.
Publicado: (2023)

Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial
por: Joseph Davey, Dvora Leah, et al.
Publicado: (2022)

Pre-exposure Prophylaxis Recent Adherence With Real-Time Adherence Feedback and Partner Human Immunodeficiency Virus Self-Testing: A Pilot Trial Among Postpartum Women
por: Joseph Davey, Dvora Leah, et al.
Publicado: (2021)

Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa
por: Khadka, Nehaa, et al.
Publicado: (2023)

Integration of HIV pre-exposure prophylaxis (PrEP) services for pregnant and breastfeeding women in eight primary care clinics: results of an implementation science study
por: Nelson, Aurelie, et al.
Publicado: (2023)

Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study
por: Joseph Davey, Dvora, et al.
Publicado: (2022)

The importance of assessing and addressing mental health barriers to PrEP use during pregnancy and postpartum in sub‐Saharan Africa: state of the science and research priorities
por: Stanton, Amelia M., et al.
Publicado: (2022)

Assessing the Impact of a PrEP Aware Week Campaign on PrEP Prescription Fills in NYS
por: Tesoriero, James M., et al.
Publicado: (2022)

What motivated men to start PrEP? A cross-section of men starting PrEP in Buffalo city municipality, South Africa
por: Smith, Philip John, et al.
Publicado: (2023)

The importance of PrEP persistence in preventing HIV infections on PrEP
por: Spinelli, Matthew A, et al.
Publicado: (2020)

HIV risk, risk perception, and PrEP interest among adolescent girls and young women in Lilongwe, Malawi: operationalizing the PrEP cascade
por: Hill, Lauren M, et al.
Publicado: (2020)

“PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women
por: Pasipanodya, Elizabeth C., et al.
Publicado: (2021)

Safety surveillance for PrEP in pregnant and breastfeeding women
por: Fairlie, Lee, et al.
Publicado: (2023)

Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out
por: Joseph Davey, Dvora, et al.
Publicado: (2022)

PrEP implementation research in Africa: what is new?
por: Cowan, Frances M, et al.
Publicado: (2016)

Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial
por: Beesham, Ivana, et al.
Publicado: (2022)

PrEP-RN: Clinical Considerations and Protocols for Nurse-Led PrEP
por: O'Byrne, Patrick, et al.
Publicado: (2019)

1287. PrEP-Engaged or PrEP Curious?: A Characterization and Comparison of Initial PrEP Appointment Attenders vs. Nonattenders
por: Kahal, Deborah A, et al.
Publicado: (2019)

Predictors of PrEP awareness, PrEP discussion and interest in long‐acting injectable PrEP among Filipina transfeminine adults
por: Restar, Arjee Javellana, et al.
Publicado: (2023)

Slow Uptake of PrEP: Behavioral Predictors and the Influence of Price on PrEP Uptake Among MSM with a High Interest in PrEP
por: van Dijk, Mart, et al.
Publicado: (2021)

Efficiency in PrEP Delivery: Estimating the Annual Costs of Oral PrEP in Zimbabwe
por: Mangenah, Collin, et al.
Publicado: (2021)

PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV
por: Hill, Kristi C, et al.
Publicado: (2022)

Complex PrEP: the factors requiring consultant-led review of PrEP users
por: Tittle, Victoria, et al.
Publicado: (2022)

“You can’t have a PrEP program without a PrEP Coordinator”: Implementation of a PrEP panel management intervention
por: Saberi, Parya, et al.
Publicado: (2020)

Response to “Oral PrEP for young African women and men”
por: Celum, Connie L, et al.
Publicado: (2016)

Contracting HIV or Contracting SAR-CoV-2 (COVID- 19) in Pregnancy? Balancing the Risks and Benefits
por: Joseph Davey, Dvora, et al.
Publicado: (2020)

981. Extended Adherence and Persistence to HIV PrEP in a Multidisciplinary PrEP Clinic
por: Whelchel, Kristen, et al.
Publicado: (2020)

Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP
por: Celum, Connie, et al.
Publicado: (2023)

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
por: Donnell, Deborah, et al.
Publicado: (2023)

“Yes, I’m interested in taking PrEP!”: PrEP interest among women respondents to the European community-based survey “Flash! PrEP in Europe”
por: Delabre, Rosemary M., et al.
Publicado: (2021)

Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study
por: Amico, K. Rivet, et al.
Publicado: (2016)

52. PrEP Adherence and Discontinuation at a Pharmacy-Supported PrEP Program in Atlanta, GA
por: Yacout, Hiba, et al.
Publicado: (2021)

Understanding the Association between PrEP Stigma and PrEP Cascade Moderated by the Intensity of HIV Testing
por: Zhang, Chen, et al.
Publicado: (2022)

PrEP Acceptance among Eligible Patients Attending the Largest PrEP Clinic in Jackson, Mississippi
por: Hollcroft, Madison R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qkvug5jorotfilo4ka3v11pgi7